INDIUM IN 111 OXYQUINOLINE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Indium In 111 Oxyquinoline, and when can generic versions of Indium In 111 Oxyquinoline launch?

Indium In 111 Oxyquinoline is a drug marketed by Bwxt Itg and Ge Healthcare and is included in two NDAs.

The generic ingredient in INDIUM IN 111 OXYQUINOLINE is indium in-111 oxyquinoline. There are twenty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the indium in-111 oxyquinoline profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for INDIUM IN 111 OXYQUINOLINE?
What are the global sales for INDIUM IN 111 OXYQUINOLINE?
What is Average Wholesale Price for INDIUM IN 111 OXYQUINOLINE?

Summary for INDIUM IN 111 OXYQUINOLINE

US Patents:	0
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	7
Patent Applications:	21
What excipients (inactive ingredients) are in INDIUM IN 111 OXYQUINOLINE?	INDIUM IN 111 OXYQUINOLINE excipients list
DailyMed Link:	INDIUM IN 111 OXYQUINOLINE at DailyMed

Drug patent expirations by year for INDIUM IN 111 OXYQUINOLINE

US Patents and Regulatory Information for INDIUM IN 111 OXYQUINOLINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bwxt Itg	INDIUM IN 111 OXYQUINOLINE	indium in-111 oxyquinoline	INJECTABLE;INJECTION	202586-001	Jul 25, 2018	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ge Healthcare	INDIUM IN 111 OXYQUINOLINE	indium in-111 oxyquinoline	INJECTABLE;INJECTION	019044-001	Dec 24, 1985	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for INDIUM IN 111 OXYQUINOLINE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ge Healthcare	INDIUM IN 111 OXYQUINOLINE	indium in-111 oxyquinoline	INJECTABLE;INJECTION	019044-001	Dec 24, 1985	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for INDIUM IN 111 OXYQUINOLINE

See the table below for patents covering INDIUM IN 111 OXYQUINOLINE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	0017355	INDIUM-111 OXINE COMPLEX COMPOSITION	⤷ Sign Up
Japan	S5914452		⤷ Sign Up
Germany	3062496		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for INDIUM IN 111 OXYQUINOLINE

Make Better Decisions: Try a trial or see plans & pricing